13 | $PGY 26% v9,0M c1.12 f705,343M H1.15 ML.78 | znewcar1 | 05/22/2023 6:07:41 PM |
12 | $PGY Hod1.15 ML.78 LL.57 | znewcar1 | 05/22/2023 3:36:33 PM |
11 | $PGY 22% v4,0M c1.13 f681,071M H1.19 | znewcar1 | 03/14/2023 5:09:13 PM |
10 | $PGY hod1.52 dipps | znewcar1 | 02/13/2023 10:26:50 AM |
9 | $PGY 20% v16,2M c1.24 f681,071M H1.33 ML.57 | znewcar1 | 12/28/2022 4:44:54 PM |
8 | $PGY 23% v8,7M C1.03 f681M H1.07 ML.5701 | znewcar1 | 12/27/2022 11:11:50 PM |
7 | $PGY 16% v6,5M c.664 f681,071M Hod.749 | znewcar1 | 12/20/2022 4:42:40 PM |
6 | HOD.749 YL.5702 morning pop over.6 and pushed to | znewcar1 | 12/20/2022 1:50:07 PM |
5 | lod.57 on morning flush $PGY | znewcar1 | 12/16/2022 4:59:16 PM |
4 | BD>.8 and fell fast to LOD.63 chopping | znewcar1 | 12/12/2022 3:59:49 PM |
3 | $PGY hod1.17 S@.82 R1 has room to run HH34.5 off | znewcar1 | 12/12/2022 12:58:33 PM |
2 | $PGY @.93 and building got a red line | znewcar1 | 12/12/2022 12:38:30 PM |
1 | $PGY HOD1.17 YL.72 MH1.4 S@.8ish does it hold to | znewcar1 | 12/12/2022 12:33:55 PM |
Recent Articles
- Kenneth Leech: Facing Fraud Charges for Client Mismanagement
- Brazil's Finance Minister Unveils Fiscal Package This Week
- Zeta Global Holdings Litigation: A Call for Investor Awareness
- Edwards Lifesciences Corporation Investors Urged to Act Now
- Celsius Holdings, Inc. Addresses Class Action Investor Concerns
- Risks and Opportunities for Light & Wonder, Inc. Investors
- Teva's Leadership to Discuss Innovations at Upcoming Conference
- Celebrating Thanksgiving with Free Turkeys and Unique Feasts
- Understanding Acadia Healthcare's Recent Legal Challenges
- Investors Urged to Take Action in Chipotle Class Action Case
- Warren Buffett's Heartfelt Philanthropy: Insights from His Legacy
- Innovative AI Training Solutions by Boys Town Transform Lives
- Heartland Express to Showcase Expertise at Major Conference
- Lilium N.V. Class Action Alerts Investors on Critical Deadline
- Investors Urged to Act in TMC Class Action Lawsuit Notice
- Biden’s Pardons: A Call for Cannabis Justice This Season
- Rackspace Technology's Upcoming Presentation at AI Conference
- Brian Buffini and Dr. Yun to Unveil 2025 Housing Insights
- LexinFintech Holdings Delivers Impressive Q3 2024 Financial Performance
- LeMaitre Vascular Engages Investors with Upcoming Conferences
- Hims & Hers Health Stock Surge Fueled by FDA Nomination Buzz
- Clearway Energy Expands Portfolio with New Wind Project Acquisition
- Marqeta, Inc. Investors Urged to Explore Legal Options
- Exciting Insights on Palazestrant and Ribociclib Presentation
- OnKure Therapeutics Schedules Investor Call for Key Updates
- Exciting Breakthroughs in Breast Cancer Treatment by Arvinas
- Steel Keg Association Promotes Reusable Kegs Amid Leadership Change
- Investors Urged to Join Humacyte, Inc. Class Action Lawsuit
- Minnesota's Cannabis Lottery Delayed Amid Legal Challenges
- Kohl's Welcomes Ashley Buchanan as CEO to Foster Growth
- State Street's $2.25 Billion Debt: Fostering Inclusion in Finance
- Faraday Future Reinvents Its Stock Symbol to Emphasize AI
- Golub Capital BDC Introduces Major $150 Million Note Offering
- HPH Sees Board Changes Amid Strategic Transformation
- Eastman Kodak's Strategic Pension Plan Move and Market Impact
- HPH Announces Leadership Transition and Future Focus
- SpaceX to Launch NASA's Dragonfly Mission to Titan
- Clairvest's New Partnership with Redstone Food Group
- Automotive Properties REIT Acquires Key Montreal Rental Properties
- Tim Draper Enthusiastically Predicts Bitcoin's Striking Rise
- Hennessy Advisors' ESG ETF to Transfer Listings to Nasdaq
- Agora, Inc. Sees Strategic Shifts Amid Financial Adjustments
- Hesai Group Announces Impressive Q3 2024 Financial Growth
- Creative Global Technology Holdings' Upcoming IPO Details
- Central Garden & Pet Reports Q4 Earnings: Key Insights Revealed
- Analyzing Woodward's Q4 Earnings and Future Outlook
- Blue Bird's Financial Performance in the Latest Earnings Report
- Central Garden & Pet Reports Strong Q4 Earnings Performance
- Central Garden & Pet's Strong Q4 Earnings Highlights
- Enanta Pharma's Earnings Report Highlights for Investors in 2024